These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 16163059)
1. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK. Summy JM; Trevino JG; Baker CH; Gallick GE Pancreas; 2005 Oct; 31(3):263-74. PubMed ID: 16163059 [TBL] [Abstract][Full Text] [Related]
2. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis. Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Trevino JG; Summy JM; Lesslie DP; Parikh NU; Hong DS; Lee FY; Donato NJ; Abbruzzese JL; Baker CH; Gallick GE Am J Pathol; 2006 Mar; 168(3):962-72. PubMed ID: 16507911 [TBL] [Abstract][Full Text] [Related]
4. AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Summy JM; Trevino JG; Lesslie DP; Baker CH; Shakespeare WC; Wang Y; Sundaramoorthi R; Metcalf CA; Keats JA; Sawyer TK; Gallick GE Mol Cancer Ther; 2005 Dec; 4(12):1900-11. PubMed ID: 16373705 [TBL] [Abstract][Full Text] [Related]
5. The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells. Thomas RM; Jaquish DV; French RP; Lowy AM Pancreas; 2010 Apr; 39(3):301-7. PubMed ID: 20358644 [TBL] [Abstract][Full Text] [Related]
6. Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor. Ghosh PM; Mikhailova M; Bedolla R; Kreisberg JI Am J Physiol Renal Physiol; 2001 Jun; 280(6):F972-9. PubMed ID: 11352836 [TBL] [Abstract][Full Text] [Related]
7. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419 [TBL] [Abstract][Full Text] [Related]
8. Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells. Ahn K; O YM; Ji YG; Cho HJ; Lee DH Yonsei Med J; 2018 Aug; 59(6):727-735. PubMed ID: 29978609 [TBL] [Abstract][Full Text] [Related]
9. Pomolic acid suppresses HIF1α/VEGF-mediated angiogenesis by targeting p38-MAPK and mTOR signaling cascades. Park JH; Yoon J; Park B Phytomedicine; 2016 Dec; 23(14):1716-1726. PubMed ID: 27912873 [TBL] [Abstract][Full Text] [Related]
10. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873 [TBL] [Abstract][Full Text] [Related]
11. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways. Nicolas S; Abdellatef S; Haddad MA; Fakhoury I; El-Sibai M Cells; 2019 Nov; 8(11):. PubMed ID: 31698752 [TBL] [Abstract][Full Text] [Related]
13. Role of epidermal growth factor and ErbB2 receptors in 3T3-L1 adipogenesis. Harrington M; Pond-Tor S; Boney CM Obesity (Silver Spring); 2007 Mar; 15(3):563-71. PubMed ID: 17372305 [TBL] [Abstract][Full Text] [Related]
14. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells. Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489 [TBL] [Abstract][Full Text] [Related]
16. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling. Sun Y; Wu C; Ma J; Yang Y; Man X; Wu H; Li S Exp Cell Res; 2016 Oct; 347(2):274-82. PubMed ID: 27426724 [TBL] [Abstract][Full Text] [Related]
18. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells. Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048 [TBL] [Abstract][Full Text] [Related]
19. p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression. Wu W; Silbajoris RA; Whang YE; Graves LM; Bromberg PA; Samet JM Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L883-9. PubMed ID: 15980035 [TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts. Park CH; Chung JH J Dermatol Sci; 2011 Nov; 64(2):134-41. PubMed ID: 21872446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]